RB PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
29-06
micro format · 32 days before the deadline
2025
23-07
micro format · 8 days before the deadline
2024
31-12
Financial
Back to profitnet €14,498
The net result is €14,498, after one loss-making year.
09-07
micro format · 22 days before the deadline
2023
31-12
Financial
Weakest financial yearnet -€33,293
The net result drops to -€33,293, the lowest from 2018 to 2025. It recovers the following year.
05-09
full format · 36 days late
2022
31-12
Financial
Highest result from 2018 to 2025net €67,883 ▲5.1%
The operating result of €90,033 and the net result of €67,883 are both a record.
31-12
Financial
Equity above €200,000equity €204,239 ▲49.8%
After 3 profitable years in a row, equity reaches €204,239.
19-09
micro format · 50 days late
14-04
Founder · Incorporation
2021
31-12
Financial
Liquidity more than doubledcurrent ratio 3.32
The current ratio rises from 1.17 to 3.32. Short-term debt falls from €35,455 to €35,194.
31-12
Financial
Equity above €100,000equity €136,355 ▲90%
After 2 profitable years in a row, equity reaches €136,355.
Show earlier events
30-08
micro format · 30 days late
2020
31-12
Financial
Back to profitnet €36,480
The net result is €36,480, after one loss-making year.
31-08
micro format · 31 days late
2019
22-08
micro format · 22 days late
2018
29-08
micro format · 29 days late
2017
25-08
micro format · 25 days late
2013
22-02
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank